Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
Titel:
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
Auteur:
Straus, David J Długosz-Danecka, Monika Connors, Joseph M Alekseev, Sergey Illés, Árpád Picardi, Marco Lech-Maranda, Ewa Feldman, Tatyana Smolewski, Piotr Savage, Kerry J Bartlett, Nancy L Walewski, Jan Ramchandren, Radhakrishnan Zinzani, Pier Luigi Hutchings, Martin Munoz, Javier Lee, Hun Ju Kim, Won Seog Advani, Ranjana Ansell, Stephen M Younes, Anas Gallamini, Andrea Liu, Rachael Little, Meredith Fenton, Keenan Fanale, Michelle Radford, John